Bulgaria - bulgarsk - myHealthbox

icn switzerland ag - Симетикон - перорални капки, емулсия - 40 mg/ml - 30 ml - Силикони

Bulgaria - bulgarsk - myHealthbox

icn switzerland ag - Симетикон - таблетки за дъвчене - 40 mg - Силикони

Den europeiske union - tsjekkisk - EMA (European Medicines Agency)

bayer ag - riociguat - hypertenze, plicní - antihypertenzíva pro plicní arteriální hypertenzi - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. Účinnost byla prokázána v pau populace, včetně etiologie idiopatické nebo dědičné pah nebo pah spojenou s onemocněním pojivové tkáně. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.

USA - engelsk - NLM (National Library of Medicine)

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - carmustine (unii: u68wg3173y) (carmustine - unii:u68wg3173y) - carmustine 100 mg in 30 ml - bicnu® (carmustine for injection) is indicated as palliative therapy as a single agent or in established combination therapy in the following: - brain tumors glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma, and metastatic brain tumors. - multiple myeloma in combination with prednisone. - relapsed or refractory hodgkin's lymphoma in combination with other approved drugs. - relapsed or refractory non-hodgkin's lymphomas in combination with other approved drugs. bicnu is contraindicated in patients with previous hypersensitivity to bicnu or its components. risk summary bicnu (carmustine for injection) can cause fetal harm when administered to a pregnant woman based on the mechanism of action [see clinical pharmacology (12.1) ] and findings in animals [see data] . limited available data with bicnu use in pregnant women are insufficient to inform a drug-associated risk of major birth defects and miscarriage. carmustine was embryotoxic in rats and rabbits and teratogenic in rats (thoracoabd

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

emcure pharmaceuticals pty ltd - carmustine, quantity: 100 mg - injection, powder for - excipient ingredients: - indications as at 16 december 1985: carmustine is indicated as palliative therapy as a single agent or in established combination therapy with other approved chemotherapeutic agents in the following: 1. malignant glioma. 2. multiple myeloma: in combination with prednisone. 3. hodgkin's disease: as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy. 4. non-hodgkins lymphomas: as secondary therapy in combination with other approved drugs for patients who relapse while being treated with primary therapy or who fail to respond to primary therapy.

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

stada arzneimittel ag, bad vilbel array - 8494 azacitidin - prášek pro injekční suspenzi - 25mg/ml - azacitidin

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

stada arzneimittel ag, bad vilbel array - 15519 pregabalin - tvrdá tobolka - 150mg - pregabalin

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

stada arzneimittel ag, bad vilbel array - 15519 pregabalin - tvrdá tobolka - 75mg - pregabalin

Canada - engelsk - Health Canada

marcan pharmaceuticals inc - carmustine - powder for solution - 100mg - carmustine 100mg - antineoplastic agents

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

carmustine -